Posters

Retinal artery macroaneurysm with different presentations and treatment choices.

Poster Details

First Author: O.Kayikcioglu TURKEY

Co Author(s):    F. Bicak   H. Mayali   E. Kurt   S. Ilker                    

Abstract Details



Purpose:

To present cases of retinal artery macroaneurysm with different clinical pictures and possible treatment choices

Setting:

University clinic as tertiary referral centre

Methods:

Retinal artery macroaneurysm cases seen recently in our clinic was presented with different imaging modalities: OCT, FFA, wide angle FFA. Therapy for the disease is also discussed for which we used perianeurysmal laser photocoagulation, YAG hyaloidotomy and anti-VEGF injections besides control of systemic hypertension.

Results:

CASE 1: A 67 years-old male patient with diabetes of 18 years duration had 8 doses of monthly ranibizumab intravitreal injeciton due to cystoid macular edema. He developed a macroaneurysm in the meantime in RE superotemporal quadrant. Visual acuity was 0.7 RE, 0.4 LE ; OCT and FFA pictures are presented. He still gets intravitreal anti-VEGF injections. CASE 2: A 62 years-old female patient with systemic hypertension had bilateral 0.8 visual acuity. She had macroaneurysm in the RE with exudation in inferotemporal quadrant. Peri aneuriysmal retina was lasered with 532nm green Pascal laser. CASE 3: A 76 years old male evaluated for retinal haemorrhages. He had bilateral cataract operation with pseudophakia, RE had 0.5 LE had 1.0 visual acuity. RE had retinal haemorrhage in superotemporal quadrant. Laser to perianeurismal area was offered again. CASE 4: A 70 years-old male patient with systemic hypertension had decreased visual acuity in the LE with finger counting vision. This patient had subhyaloidal haemorrhage which was drained by YAG laser inferior hyaloidotomy with 8mJ power. Visual acuity increased to 0.4 level in two months, perianeurismal retina was lasered later on.

Conclusions:

Patient charactheristics and pictures are presented fort his vascular problem for which systemic regulation of hypertension, retinal laser photocoagulation and anti-VEGF therapy and pars plana vitrectomy for dense intravitreal haemorrhage can be suggested.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy